Quantitative enrichment of amyloid precursors refines mass spectrometry-based amyloidosis diagnosis
Preprint
- 14 November 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Introduction Amyloidosis typing is crucial to determine the best therapeutic strategy for patients. Since conventional histological techniques often fail, the identification of amyloid precursors by mass spectrometry became the new standard. However, without quantification, selecting the amyloid precursor from proteins that may be ubiquitous under non-pathological conditions may be equivocal. Therefore, we quantified protein enrichment in amyloid deposits to improve amyloidosis typing. Methods Protein enrichment was measured by extracted ion chromatogram-based label free quantification by comparing a microdissected amyloid area with a non-amyloid area. We assessed the discrimination ability of candidate precursors with this approach compared to the two practiced identification methods. Results As a proof-of-concept, we selected 9 cases including the most common amyloidosis subtypes, 6 typed by immunohistochemistry and 3 inconclusive by immunohistochemistry. Proteins associated with amyloid deposits were identified in all samples, confirming the pathology. Where the routine clinical mass spectrometric identification techniques allowed unambiguous conclusions for 3 of 9 cases, quantification of the enrichment ratio in amyloid deposits allowed unambiguous precursor selection in all cases. Conclusion Quantification of precursor enrichment in amyloid deposits is a promising optimization for amyloidosis typing. Incorporated into routine clinical processes, it will improve patient care in difficult diagnostic situations.Keywords
All Related Versions
- Version 1, 2025-11-14, Research Square
- Published version: Clinical Proteomics, 23 (1).
This publication has 23 references indexed in Scilit:
- The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosisThe Journal of Pathology: Clinical Research, 2019
- Optimal conditions and the advantages of using laser microdissection and liquid chromatography tandem mass spectrometry for diagnosing renal amyloidosisClinical and Experimental Nephrology, 2018
- Development and Validation of Mass Spectrometry‐Based Targeted Analysis for Amyloid ProteinsProteomics – Clinical Applications, 2017
- Increasing the accuracy of proteomic typing by decellularisation of amyloid tissue biopsiesJournal of Proteomics, 2017
- Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding riskHepatology, 2017
- Identification of amyloid precursor protein from autopsy and biopsy specimens using LMD-LC-MS/MS: the experience at Kumamoto UniversityAmyloid, 2017
- Systemic amyloidosisThe Lancet, 2016
- Methods and Algorithms for Quantitative Proteomics by Mass Spectrometry2013
- Quantitative mass spectrometry in proteomics: critical review update from 2007 to the presentAnalytical and Bioanalytical Chemistry, 2012
- Probability-based protein identification by searching sequence databases using mass spectrometry dataElectrophoresis, 1999